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Objectives The aim of this study was to compare the electrophysiologic substrate in ischemic cardiomyopathy (ICM) pa-
tients with and without sustained monomorphic ventricular tachycardia (SMVT).
Background Despite the universal presence of potentially arrhythmogenic left ventricular (LV) scarring, it is not clear why the
majority of ICM patients never develop SMVT.
Methods Detailed electroanatomic mapping of the LV endocardium was performed in 17 stable control ICM patients (16
males) without clinical SMVT. They were compared with 17 ICM patients (15 males) with spontaneous SMVT.
Standard definitions of low-voltage zones and fractionated, isolated, and very late potentials were used.
Results There were no significant baseline differences between the groups in terms of LV diameter, ejection fraction
(27% vs. 28%), infarct territory, or time from infarction. However, control patients had smaller total low-voltage
area 1.5 mv (30% of surface area vs. 55%, p  0.001); smaller very low-voltage area 0.5 mv (7.3% vs. 29%,
p  0.001); higher mean voltage of low-voltage zones; fewer fractionated, isolated, and very late potentials with
lower density of these scar-related electrograms per unit low-voltage area; and less SMVT inducibility. Potential
conducting channels within dense scar and adjacent to the mitral annulus were more frequent in SMVT patients.
Conclusions Compared with ICM patients with SMVT, an otherwise similar control group demonstrated markedly smaller en-
docardial low-voltage zones, lower scar-related electrogram density, and fewer conducting channels with faster
conduction velocity. These findings may explain why some ICM patients develop SMVT and others do not.
(J Am Coll Cardiol 2009;54:166–73) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.024e
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dhe pathologic and electrophysiologic substrate for sus-
ained monomorphic ventricular tachycardia (SMVT) in the
hronic phase after myocardial infarction (MI) has been well
haracterized (1). Inhomogeneous scarring with varying
egrees of subendocardial myocardial fiber preservation
ithin dense zones of fibrosis results in slowed conduction,
onuniform anisotropy, and the presence of conduction
hannels leading to the development of re-entrant ventric-
lar tachycardia (2,3). In the ablation era, high-density
rom the Department of Cardiology, Royal Melbourne Hospital and the Department
f Medicine, University of Melbourne, Melbourne, Australia. Drs. Haqqani and
oberts-Thomson are the recipients of Postgraduate Medical Scholarships from the
ational Health and Medical Research Council of Australia as well as Cardiovascular
ipid Grants.s
Manuscript received January 15, 2009; revised manuscript received March 30,
009, accepted April 20, 2009.lectroanatomic mapping has been used to characterize the
lectrical correlates of this well-described pathologic sub-
trate (4). Scar border zone regions as well as isolated and
ery late potentials within otherwise apparently dense scar
See page 174
ppear to represent critical components of the re-entrant
ircuit and have all been targeted with successful long-term
blation outcomes (5–7). However, it is unknown why the
ajority of patients with extensive ventricular scarring from
arge infarcts and ischemic cardiomyopathy (ICM) do not
evelop SMVT (8).
In this study we compared the electrophysiologic sub-trate in stable ICM patients with no clinical history of
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July 7, 2009:166–73 Substrate in Absence of Ventricular TachycardiaMVT with that of an otherwise matched group of patients
ith spontaneous clinical SMVT. We hypothesized that
ifferences in endocardial substrate characterized by a high-
ensity electroanatomic map would account for the differ-
nce in SMVT incidence between the groups.
ethods
atient population. We studied a control group of stable
CM patients who had no history of spontaneous clinical
MVT. They were enrolled prospectively from a popula-
ion referred for prophylactic implantable cardioverter-
efibrillator (ICD) insertion based on accepted primary
revention criteria (9). Inclusion criteria were as follows: 1)
arlier MI(s) with more than 3 months elapsed since the
ost recent MI; 2) moderate-to-severe left ventricular (LV)
ystolic dysfunction with ejection fraction (EF) 40%; and
) no history of clinical ventricular arrhythmias, syncope,
ardiac arrest, or undiagnosed palpitations. These patients
omprised the control group and are referred to as Group 1.
The control group was compared with a group of ICM
atients with a history of symptomatic SMVT (Group 2).
nclusion criteria for these patients were similar to those for
roup 1 except they were also required to have had at least
clinical SMVT episode, including those terminated by
CD therapy. The majority of this group (15 of 17 patients)
as enrolled from consecutive patients undergoing
ubstrate-based catheter ablation of SMVT causing fre-
uent ICD therapies. Members of this group were also
nrolled from patients undergoing electrophysiologic stud-
es after presenting with SMVT before ICD insertion.
Exclusion criteria were: 1) angina, acute coronary syn-
rome, or MI within the last 3 months; 2) surgical or
ercutaneous revascularization within the last 3 months; 3)
ecompensated cardiac failure within the last month; 4)
ntracardiac thrombus; 5) uncontrolled hypertension; 6)
ctive cerebrovascular disease; 7) severe aorto-iliac periph-
ral vascular disease; 8) any contradiction to anticoagulation;
nd 9) inability to provide informed consent.
All patients provided informed consent, and the protocol
as approved by the Human Research Ethics Committee of
elbourne Health.
rotocol. Programmed ventricular stimulation and electro-
natomic LV endocardial mapping was performed in both
roups.
ROGRAMMED VENTRICULAR STIMULATION. Patients were
tudied in the post-absorptive state, after echocardiography
xcluded LV thrombus. A hexapolar catheter was advanced
o the right ventricle. Stimulation was performed at twice
he diastolic threshold from the right ventricular apex and
ight ventricular outflow tract. Four extrastimuli were de-
ivered during 400- and 350-ms basic drive cycle lengths,
ith simultaneous stepwise 10-ms decrements in the cou-
ling intervals of all 4 extrastimuli until the first extrastimu-
us reached a coupling interval of 200 ms or was refractory.
nduced ventricular tachycardias were analyzed for cycleength, morphology, axis, hemo-
ynamic and morphological stabil-
ty, and induction and termination
haracteristics. All induced SMVTs
n Group 2 ablation patients were
argeted for ablation.
LECTROANATOMIC MAPPING.
fter programmed stimulation,
ndocardial LV electroanatomic
apping was performed in the
asal rhythm using a retrograde
pproach via the right common
emoral artery. Systemic antico-
gulation with intravenous un-
ractionated heparin was initi-
ted, aiming for an activated
lotting time of 250 s.
A 3.5-mm tip electroanatomic
apping catheter with 2-mm
ing electrode and 1-mm interelectrode spacing (Navistar,
iosense Webster, Diamond Bar, California) was used. A
-dimensional shell of the chamber geometry was con-
tructed and electrograms were systematically recorded from
he entire LV endocardium. Fluoroscopy and signal char-
cteristics, in addition to electroanatomic stability, were
sed to verify stable endocardial catheter contact before
oints were acquired. Bipolar electrograms were filtered at
.5 to 400 Hz and displayed at 200 mm/s on the CARTO
Biosense Webster) mapping system. Valvular locations
ere defined by electrograms and fluoroscopy. Mapping
ensity was uniform across the LV endocardium and was
ufficient to allow a fill threshold of 15 mm. An effort was
ade to obtain equal scar sampling density in all patients.
Acquired bipolar electrograms were analyzed for stability,
mplitude, duration, morphology, and timing relative to the
urface QRS complex and were displayed as isopotential
aps on the CARTO system. The incorporated software
as then used to measure chamber volume and surface area,
s well as low-voltage areas. The total low-voltage zone
TLZ) was defined as the area displaying bipolar voltage of
1.5 mV and very low-voltage zones (VLZ) had bipolar
oltage 0.5 mV (7). Points with bipolar voltage between
.5 and 1.5 mV were labeled intermediate low-voltage zones
ILV) (7).
Electrograms were classified by 2 independent observers
ccording to standard criteria (10) and modified for use with
he recording system (11) into 1 of the following groups:
. Normal electrograms with 3 or fewer sharp intrinsic
deflections from baseline, amplitude 3 mV, duration
70 ms, and/or amplitude/duration 0.046.
. Fractionated potentials with multiple intrinsic deflec-
tions, amplitude 0.5 mV, duration 133 ms, and/or
Abbreviations
and Acronyms
EF  ejection fraction
ICD  implantable
cardioverter-defibrillator
ICM  ischemic
cardiomyopathy
ILZ  intermediate
low-voltage zone
LV  left ventricle
MI  myocardial infarction
SMVT  sustained
monomorphic ventricular
tachycardia
TLZ  total low-voltage
zone
VLZ  very low-voltage
zoneamplitude/duration 0.005.
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Substrate in Absence of Ventricular Tachycardia July 7, 2009:166–73. Isolated potentials were those displaying an additional
signal separated from the local ventricular electrogram by
a 20-ms isoelectric interval (11).
. Very late potentials were electrograms with an isolated
component occurring 100 ms after the QRS.
. Any electrograms not fitting into 1 of these categories
were classified as nonfractionated abnormal electrograms.
The presence of potential conducting channels associated
ith the VLZ was inferred from observation of 1 of the
ollowing characteristics: 1) a corridor of preserved voltage
etween VLZ and adjacent valve annulus (“mitral isthmus
hannels”) (12,13); 2) a region of higher amplitude signals
ithin the VLZ that could be seen after isopotential
hreshold adjustment on the CARTO system (“voltage
hannels”) (14,15); and 3) very late potentials (100 ms
fter the end of the QRS) within VLZs. Regional conduc-
ion velocity in the 4 quadrants of the periannular region
as determined from the CARTO software by measuring
he distance between activation points orthogonal to iso-
hronal lines.
tatistical analysis. All continuous data are presented as
ean  1 SD. Baseline and mapping data were analyzed by
he chi-square test (or Fisher exact test where appropriate),
nd with the Mann-Whitney U test. A value of p  0.05
as considered statistically significant.
esults
aseline characteristics. Baseline characteristics of the
atients are presented in Table 1. Twenty-one patients with
o history of clinical ventricular arrhythmias were enrolled
aseline Characteristics
Table 1 Baseline Characteristics
Characteristic
Group 1:
Control
Patients
Group 2:
SMVT
Patients
p
Value
n 17 17
Mean age, yrs 59 11 67 6.1 0.03
Male 16 15 NS
Anterior infarct 11 8 NS
Inferior infarct 6 9 NS
Mean time since infarct, months 93 87 110 55 NS
Ejection fraction, % 26 6 28 9 NS
LV diastolic dimension, mm 68 7 65 9 NS
Acute reperfusion therapy 13 14 NS
Coronary bypass surgery 8 8 NS
Atrial fibrillation 2 2 NS
NYHA functional class 1/2/3 9/8/0 6/9/2 NS
ACE inhibitor or ARB 17 15 NS
Beta-blocker 15 14 NS
Amiodarone 0 16 0.001
Other antiarrhythmic drugs 0 13 0.001
Left bundle branch block 7 7 NS
QRS duration, ms 132 31 144 32 NS
ata are given as n or mean  SD.
ACE  anigotensin-converting enzyme; ARB  angiotensin receptor blocker; LV  left ventricu-
ar; NYHA New York Heart Association; SMVT sustained monomorphic ventricular tachycardia.n Group 1 but 4 were excluded due to LV thrombus or oeripheral vascular disease. The remaining 17 patients who
nderwent LV endocardial mapping were compared with a
roup of 17 consecutive post-infarction patients who had
pontaneous SMVT (Group 2).
Overall, the groups were similar (Table 1), notably, in
erms of LV size and systolic function, time since myocar-
ial infarction, revascularization, infarct distribution, and
ew York Heart Association functional class. All patients
ad undergone recent angiography or stress perfusion scin-
igraphy to exclude active ischemia. Background cardiac
ailure medical therapy was excellent in both groups. Group
control patients were significantly younger on average
mean age 59  11 years vs. 67  6.1 years, p  0.03). No
ontrol patients were on amiodarone or other membrane
ctive antiarrhythmic drugs, but there was an almost uni-
orm use of antiarrhythmic drugs in the 17 SMVT patients
o treat their index arrhythmias at the time of presentation
Table 1). These drugs included sotalol (mean daily dose
13 mg) in 6 patients, procainamide (maintenance intrave-
ous infusion) in 2 patients, quinidine (mean daily dose,
.2 g) in 3 patients, flecainide (mean daily dose, 250 mg) in
patients, and mexilitene (mean daily dose, 675 mg) in 8
atients, and these were ceased before the mapping proce-
ure. Sixteen of 17 SMVT patients were being treated with
aintenance doses of amiodarone at the time of presenta-
ion and this was continued in all patients at the time of
apping.
V voltage mapping. The results of electroanatomic map-
ing are presented in Table 2. The mean number of tip
oints sampled was comparable between the groups (240 
6 points in Group 1; 234  42 points in Group 2; p 
S). There were no significant differences between the 2
roups in terms of LV volume or total mapped endocardial
urface area.
The areas of both the TLZ (bipolar voltage 1.5 mV) and
he VLZ (0.5 mV) were significantly smaller in Group 1
ontrol patients compared with Group 2 SMVT patients
Table 2). An example of the endocardial voltage map from
atients in each group is shown in Figure 1A. Differences in
oltage persisted when controlled for LV endocardial surface
rea (Fig. 1B), and were not due to different point sampling
lectroanatomic Mapping Data
Table 2 Electroanatomic Mapping Data
Data
Group 1:
Control
Patients
Group 2:
SMVT
Patients
p
Value
Tip points, n 240 96 234 42 NS
LV volume, ml 247 60 245 97 NS
LV surface area, cm2 258 37 237 64 NS
TLZ (1.5 mV) area, cm2 78 30 132 64 0.009
VLZ (0.5 mV) area, cm2 19 15 70 31 0.001
ILZ (0.5–1.5 mV) area, cm2 58 22 62 41 NS
VLZ as percent of TLZ area, % 23 13 55 15 0.001
VLZ sampling density, points/cm2 2.3 1.8 1.5 0.6 NS
ata are presented as mean  SD.
ILZ intermediate low-voltage zone; TLZ total low-voltage zone; VLZ very low-voltage zone;
ther abbreviations as in Table 1.
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July 7, 2009:166–73 Substrate in Absence of Ventricular Tachycardiaensity (Table 2). In addition, the proportion of the TLZ that
as composed of very low voltage was significantly less in the
ontrol group (Table 2). There was no significant difference
etween the groups with respect to the area of the intermediate
ow-voltage zone (ILZ) (bipolar voltage 0.5 to 1.5 mV) (Table
). This zone was uniformly found surrounding the VLZ and
ost likely represents the scar-border zone. Within both the
LZ and VLZ, the mean bipolar voltage was significantly
ower in Group 2 SMVT patients than in Group 1 control
atients (Fig. 1C).
lectrogram and channel characteristics. When consider-
ng the entire endocardial map, fractionated and isolated
otentials were significantly more prevalent in the Group 2
SMVT) patients than in the control group (Fig. 2B). Very late
otentials were essentially seen in the SMVT group only.
ithin the total, intermediate and very low-voltage zones
here was also a significantly higher prevalence of fractionated,
solated, and very late potentials in Group 2 (SMVT) patients
Figure 1 Electroanatomic Mapping Data
(A) shows an example of typical isopotential maps seen in both groups. Bipolar voltag
purple. The map on the left is from a 58-year-old man with severe ICM (EF 18%) after
9% of the LV surface area. A 67-year-old man with similarly severe ICM and spontaneo
VLZ accounting for 44% of the LV surface is present. The mean proportionate low-volta
amplitudes in these regions were significantly higher in the control patients (C). EF 
ventricular; MI  myocardial infarction; SMVT  sustained monomorphic ventricular taespite equal low-voltage zone point sampling density (Table w). These differences persisted for fractionated and very late
otential prevalence when controlled for TLZ surface area
Fig. 2C). However, the difference in isolated potential density
id not reach statistical significance.
There was an increased prevalence of putative conducting
hannels in the SMVT group (Table 4). More Group 2
atients displayed mitral isthmus channels and voltage chan-
els, and very late potentials (reflecting electrically conducting
egions within dense VLZs) were largely found in this group
lone. Examples of these are depicted in Figure 3.
rogrammed ventricular stimulation. The results of pro-
rammed stimulation are summarized in Table 5. Group 2
atients with clinical tachycardia were more likely to be
nducible and had a greater number of induced SMVTs. Of
he total 68 induced SMVTs in Group 2, 30 were of left
undle branch block morphology and 38 had right bundle
ranch block configuration. Four induced tachycardias in
roup 1 were of left bundle branch block morphology and 2
.5 mV (VLZ) are depicted in red, with normal myocardium (1.5 mV) represented by
anterior MI 9 years earlier with no clinical arrhythmias. The VLZ accounts for only
VT 13 years after anterior MI is shown on the right. A large confluent anteroapical
as are shown in B, with markedly larger VLZ and TLZ in Group 2. The mean signal
n fraction; ICM  ischemic cardiomyopathy; LAO  left anterior oblique; LV  left
dia; TLZ  total low-voltage zone; VLZ  very low-voltage zone.es 0
a large
us SM
ge are
ejectio
chycarere of right bundle branch block pattern. A greater propor-
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Substrate in Absence of Ventricular Tachycardia July 7, 2009:166–73ion of the induced SMVTs were mappable in Group 2
ompared with Group 1, although a high prevalence of
nmappable SMVT was seen in both groups. The majority of
nducible patients in both groups had no mappable SMVT.
The 4 inducible Group 1 control patients had no demon-
trable substrate differences compared with the 13 nonin-
Figure 2 Electrogram Prevalence and Density
The right anterior oblique projections of the 2 patients from Figure 1 are shown in
light blue, isolated potentials (IP) in white, and very late potentials (VLP) in gray.
der; IP and VLP were found deeper inside the VLZ. In the control patient, there is
the smaller low-voltage zone. The global prevalence of scar-related electrograms w
the composition and potential arrhythmogenicity of the abnormal substrate are su
low-voltage zone area. Abbreviations as in Figure 1.
ow-Voltage Zone Electrogram Characteristics
Table 3 Low-Voltage Zone Electrogram Characteristics
Characteristic
Group 1:
Control
Patients, %
Group 2:
SMVT
Patients, %
p
Value
VLZ (0.5 mV)
Fractionated potentials 38.8 21 47.9 19 NS
Isolated potentials 12.0 12 24.8 14 0.01
Very late potentials 0.49 1.6 9.3 8.6 0.001
ILZ (0.5–1.5 mV)
Fractionated 0.79 1.2 7.7 6.6 0.001
Isolated potentials 10.6 8.5 23.1 11 0.001
Very late potentials 0 5.0 5.2 0.001
TLZ (1.5 mV)
Fractionated 7.3 4.8 29.6 13 0.001
Isolated potentials 11.2 8.7 25.0 12 0.001
Very late potentials 0.06 0.17 7.5 6.7 0.001ata are presented as mean  SD.
Abbreviations as in Table 2. Sucible control patients. The TLZ (38.3  10.5% of LV
urface area in the inducible patients vs. 27.5  9.5% in the
oninducible patients, p  NS) or VLZ (12.0  6.1% vs.
.8  5.1%, respectively, p  NS) proportionate areas did
ot significantly differ between the inducible and noninduc-
ble control patients, nor did the prevalences of fractionated
4.2  1.5% vs. 3.3  2.6%, p  NS), isolated (8.5  6.2%
s. 4.4  3.3%, p  NS), or very late potentials (0.05 
.1% vs. 0.03  0.08% respectively, p  NS).
iscussion
his study showed significant differences in the endocardial
V electrophysiologic substrate between patients with and
ithout clinical SMVT (rather than inducible SMVT) and
scar-related electrograms annotated as follows: fractionated potentials (FP) in
SMVT patient at the bottom of the panel, FPs were found around the VLZ bor-
eme paucity of scar-related electrograms despite high-density point sampling in
nificantly greater in the SMVT group as shown in B. Fundamental differences in
d by the data in C, where Group 2 has a higher density of FP and VLP per unit
utative Conducting Channel Characteristics
Table 4 Putative Conducting Channel Characteristics
Characteristic
Group 1:
Control
Patients
Group 2:
SMVT
Patients
p
Value
Mitral isthmus channel 7 15 0.005
Voltage channel 10 17 0.015
Patients with VLP in dense scar 2 15 0.001
Mean VLPs/patient 1.5 13.4 0.001A with
In the
an extr
as sig
ggesteMVT  sustained monomorphic ventricular tachycardia; VLP  very late potential.
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July 7, 2009:166–73 Substrate in Absence of Ventricular Tachycardiaxpanded on previous observations. We demonstrated that
hen compared with ICM patients with SMVT, a control
roup with similar infarct size, EF, and time since infarct
emonstrated: 1) markedly smaller endocardial low-voltage
ones; 2) a lower prevalence of fractionated, isolated, and very
ate potentials; 3) fewer putative conducting channels; and 4)
ifferent low-voltage zone characteristics with more preserved
oltages, and lower fractionated, isolated, and very late poten-
ial density. These observations may in part explain the
ifference in SMVT incidence between the groups.
Figure 3 Putative Conducting Channels
An example of isopotential adjustment to show potential channels of higher region
after inferior MI, and frequent SMVT. B shows a large area of confluent dense late
recurrent SMVT requiring ICD therapy. The left side shows an area of lateral very l
age preservation adjacent to the mitral annulus. The marker tags represent points
superior mitral isthmus and was ablated here. All these channel types were less c
tor; VLP  very late potential; other abbreviations as in Figure 1.
Inducibility With Programmed Stimulation
Table 5 Inducibility With Programmed Stimu
Variable
Gro
Contro
Patients with inducible SMVT, n (%) 4 (2
SMVTs induced, n (range) 6 (1
Mean cycle length, ms (range) 265 (2
Mappable SMVTs, n (%) 0 (0
Patients with mappable SMVT, n
Patients with PVT or VF, nPVT  polymorphic ventricular tachycardia; SMVT  sustained monomorphicarlier studies. Two earlier studies examined the myocardial
ubstrate in patients with previous MI who did not have
linical ventricular arrhythmias. In a landmark study, Cassidy
t al. (10) used a nondeflectable catheter with 1-cm bipolar
pacing to sample from a mean of 11 LV endocardial sites in
group of ischemic and dilated cardiomyopathy patients.
heir study included 9 patients with previous MI and no
linical SMVT. At the 11 sites sampled, these patients dem-
nstrated less endocardial fractionation than patients with
linical ventricular arrhythmias. However, a more detailed
age within the VLZ is shown in A in a 63-year-old woman with EF of 27% 8 years
rring in a 67-year-old man with earlier inferolateral infarction, EF of 24%, and
tage in the left anterior oblique projection. The right side displays a zone of volt-
VLPs were seen. One of the induced SMVTs in this patient exited from the
n in the control patients without SMVT. ICD  implantable cardioverter-defibrilla-
n
nts
Group 2:
SMVT Patients
p
Value
15 (88) 0.001
68 (1–12) 0.001
0) 360 (270–610) 0.001
28 (41) 0.05
6 NS
1 NSal volt
ral sca
ow vol
where
ommolatio
up 1:
l Patie
4)
–2)
50–29
)
0
4ventricular tachycardia; VF  ventricular fibrillation.
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Substrate in Absence of Ventricular Tachycardia July 7, 2009:166–73ssessment of the nature of the substrate could not be per-
ormed in that early study. In addition, they had less severe
ardiomyopathy than the control patients in the present study
mean EF of 40  18% compared with 26  5%). Wiener et
l. (16) also sampled a limited number of endocardial points
16 to 40 points) using a nondeflectable catheter in 11 patients
aving surgery for ventricular aneurysms, including 5 patients
ith no history of SMVT. They focused mapping to the
car-border zone and observed that patients without SMVT
ad less fractionation in this region of the aneurysm than
atients with SMVT. The extent of global endocardial low-
oltage and the presence of channels were not assessed with
his limited mapping. Although these early studies provide
ome initial insights into the mechanism of post-infarction
MVT, they do not provide the detailed electroanatomic
ubstrate analysis that has become the cornerstone of different
entricular tachycardia ablation strategies (5,7,17,18).
echanism of post-infarct ventricular tachycardia and
blation targets. The mechanism of post-infarct SMVT is
car-related re-entry in the majority of patients (1). Inhomo-
eneous scarring with varying degrees of subendocardial myo-
ardial fiber preservation within dense zones of fibrosis leads to
lowed conduction, nonuniform anisotropy, and the potential
or channels within the scar zone—conditions necessary for
he development of re-entry (2,3). In the ablation era, high-
ensity electroanatomic mapping has been used to characterize
he electrical correlates of this well-described pathologic sub-
trate, allowing for development of substrate modification
trategies (7) to target unmappable SMVTs (19). Channels
ithin a scar (isolated potentials [6,11], very late potentials) or
egions at the scar-border zone (putative exit sites) (18,20)
ppear to represent critical components of the re-entrant circuit
nd have all been targeted with successful long-term ablation
utcomes.
The current study compares these key markers of SMVT
ubstrate by creating high-density maps of the left ventricle
mean of 240 contact points) with detailed sampling from
ithin the low-voltage regions in ICM patients with and
ithout previous clinical ventricular arrhythmias. Our data
uggest that it is both the extent of the VLZ and the presence
f numerous channels within this zone that are critical to the
evelopment of ventricular arrhythmias. Although the border
one region of the scar (ILZ) did not differ in area between the
groups, in the SMVT patients, this zone also had a
ignificantly higher prevalence of putative conducting channels.
It is noteworthy that earlier pathologic (21) and radiologic
22) studies have also suggested that a higher burden of fibrosis
mplies a greater coexisting substrate for development of
MVT (and hence an increased chance of spontaneous clinical
rrhythmias), but until now detailed clinical mapping data
rom the dense scar region have been lacking.
lectrograms, SMVT substrate, and channels. Whether
ractionated, isolated, or very late potentials are the most
mportant markers of critical SMVT substrate cannot be
nswered by the current study. All 3 of these electrogram
ypes demonstrated a higher prevalence in SMVT patients cnd a higher density within the scar than in controls. This
uggests a fundamentally different scar composition (more
arrhythmogenic”) in the Group 2 SMVT patients. Nota-
ly, very late potentials were observed almost exclusively in
atients with clinical SMVT. Recent observations (W.
ackman, MD, unpublished data, 2007) have highlighted
ery late potentials as a possible ablation target. In sinus or
aced rhythm, very late potentials represent electrically
iable sites that undergo very delayed activation by slow,
erpiginous impulse propagation within scar. Although a
roportion of these potentials may represent cul-de-sacs
ithin scar, during SMVT the same sites may be an
mportant zone of constrained diastolic isthmus conduction.
In addition, channels between scar and the mitral annulus
12,13), and scar-to-scar channels (14,15) may form a
rotected isthmus that can facilitate re-entry either by slow
onduction or functional block. The current study also
emonstrated that patients with clinical SMVT had a
reater number of these putative channels than patients
ithout SMVT.
iscrepancy between infarct size and extent of low-
oltage zones. The finding of markedly smaller low-voltage
ones in the control group despite similarly large previous
I(s) and severe LV systolic dysfunction suggests a significant
egree of electromechanical uncoupling in the scarred LV
egions in these patients. It is not clear why the 2 groups should
emonstrate such significant differences in endocardial low-
oltage zone extent and characteristics. Both groups had a
imilar proportion of patients who had undergone revascular-
zation and acute reperfusion, and the mean time since index
nfarction was not significantly different. No patients had any
vidence of active myocardial ischemia. It is interesting to
peculate that increased subendocardial preservation in the
cute infarction phase, reduced post-infarct remodeling, or
iffering healing responses (perhaps genetically determined) to
I explain the markedly reduced burden of endocardial low
oltage seen in Group 1 (control) patients. Indeed the higher
ean voltage observed within the low-voltage zones of Group
compared with those in Group 2 patients also suggests
undamental differences, not only in the extent of the scar but
lso in its composition.
linical implications. Recent studies have demonstrated
hat SMVT in patients with ICM can be successfully
blated by targeting channels within (11) or between areas
f apparently dense scar (14,15), or between scar and the
itral annulus (12,13). The current study demonstrates that
hese channels are not universally present in patients with
CM and that the extent of dense scarring varies markedly.
n particular, patients without clinical ventricular tachycar-
ia had a significantly lower prevalence of channels and an
lmost complete absence of very late potentials within a
uch smaller dense scar body. This, despite the fact that
atients were otherwise similar with respect to several key
actors (infarct size, EF, time from infarct), suggests that
ot all ICM patients will inevitably develop the substrate
ritical to development of SMVT.
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July 7, 2009:166–73 Substrate in Absence of Ventricular TachycardiaIn patients with ischemic cardiomyopathy, tachycardias
ausing sudden death include SMVT, polymorphic ventricular
achycardia, or ventricular fibrillation. Whether the risk of
udden death is related to substrate features that favor SMVT
s not clear but is likely to be the case. The present study has
dentified multiple differences in the LV substrate between
atients with and without a history of clinical SMVT. This
hould stimulate further studies to determine whether these
ifferences may also translate into differing risks of sudden
ardiac death. Noninvasive techniques to determine dense scar
xtent and distribution might also be evaluated in this context.
tudy limitations. By slowing conduction velocity and alter-
ng refractoriness, clinical antiarrhythmic drug exposure could
otentially affect electroanatomic mapping findings. Differ-
nces in antiarrhythmic drug use between the 2 groups were
navoidable given the characteristics of the study groups.
owever, in the context of multiple reports of ventricular
achycardia ablation techniques targeting the SMVT substrate
ith successful outcome, it is unlikely that the markedly
iscrepant findings related to low-voltage zone area, scar
ensity, and electrogram density between the groups simply
epresent an artifact of amiodarone or other antiarrhythmic
rug use. We believe it is more likely that differences observed
ere due to the nature of the myocardial substrate.
Mapping data in this study were acquired with the use of
single commercially available electroanatomic mapping
ystem and its associated proprietary software. We cannot
xclude the introduction of a systematic bias related to this,
ut we feel this is unlikely given the widespread use of this
ystem in SMVT ablation.
onclusions
espite equally severe LV dysfunction as well as similar infarct
ge and distribution, patients without clinical SMVT had
ignificantly smaller endocardial low-voltage areas, fewer scar-
elated electrograms, and fewer potential conducting channels
ompared with similar ICM patients with spontaneous
MVT. These differences in endocardial electrophysiologic
ubstrate may play an important role in SMVT arrhythmo-
enesis in the chronic post-infarct context.
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